Xantos Biomedicine AG has approved funding from the Bavarian Ministry of Economy
Xantos Biomedicine AG announced that it has been awarded a grant from the Bavarian Ministry of Economic Affairs, Infrastructure, Transport and Technology (=BayStMWIVT) for the expansion of its technology platform. The overall aim of the project, which will run for two years, is to create innovative applications for the Xantos' service technology platform. Several modules will be implemented and improved to increase the outcome of functional screenings.
In addition the project will aim at expanding the use of the OPERA System (Evotec Technologies), a high content screening tool, which is based on confocal microscopy, broadening the range of assays to be performed significantly. In addition to that further assays will be implemented to monitor the induced cellular phenotypes with complex intracellular biology. The second goal of this project will be to improve the access to Qiagen's RNAi libraries and implementing these libraries in various novel assays and optimizing this tool in combination with the traditional overexpression approach. As announced earlier this year Xantos has signed a comarketing agreement with Qiagen. The project and grants received will allow Xantos a highly competitive positioning of its service platform.
Most read news
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.